These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1902454

  • 1. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats.
    Lai YL, Olson JW, Gillespie MN.
    J Appl Physiol (1985); 1991 Feb; 70(2):561-6. PubMed ID: 1902454
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension.
    Kawai M, Zhang E, Kabwe JC, Okada A, Maruyama J, Sawada H, Maruyama K.
    BMC Pulm Med; 2022 Mar 05; 22(1):78. PubMed ID: 35247989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Capsaicin pretreatment attenuates monocrotaline-induced ventilatory dysfunction and pulmonary hypertension.
    Zhou KR, Lai YL.
    J Appl Physiol (1985); 1993 Dec 05; 75(6):2781-8. PubMed ID: 7510280
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
    Todd L, Mullen M, Olley PM, Rabinovitch M.
    Pediatr Res; 1985 Jul 05; 19(7):731-7. PubMed ID: 3161000
    [Abstract] [Full Text] [Related]

  • 9. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.
    Ono S, Voelkel NF.
    J Appl Physiol (1985); 1991 Dec 05; 71(6):2483-92. PubMed ID: 1838107
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension.
    Chen MJ, Chiang LY, Lai YL.
    Toxicol Appl Pharmacol; 2001 Mar 15; 171(3):165-73. PubMed ID: 11243916
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension.
    Mathew R, Gloster ES, Sundararajan T, Thompson CI, Zeballos GA, Gewitz MH.
    J Appl Physiol (1985); 1997 May 15; 82(5):1493-8. PubMed ID: 9134898
    [Abstract] [Full Text] [Related]

  • 14. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
    Mathew R, Altura BT, Altura BM.
    Magnesium; 1989 May 15; 8(2):110-6. PubMed ID: 2526910
    [Abstract] [Full Text] [Related]

  • 15. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec 15; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 16. Selective right, but not left, coronary endothelial dysfunction precedes development of pulmonary hypertension and right heart hypertrophy in rats.
    Sun X, Ku DD.
    Am J Physiol Heart Circ Physiol; 2006 Feb 15; 290(2):H758-64. PubMed ID: 16172159
    [Abstract] [Full Text] [Related]

  • 17. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF, Ganey PE, Wagner JG, Slocombe RF, Roth RA.
    Toxicol Appl Pharmacol; 1990 Nov 15; 106(2):179-200. PubMed ID: 2256110
    [Abstract] [Full Text] [Related]

  • 18. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
    Gillespie MN, Olson JW, Reinsel CN, O'Connor WN, Altiere RJ.
    Am J Physiol; 1986 Jul 15; 251(1 Pt 2):H109-14. PubMed ID: 2942040
    [Abstract] [Full Text] [Related]

  • 19. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Jul 15; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 20. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar 15; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.